187 related articles for article (PubMed ID: 32181759)
1. [Molecular genetic methods used in diagnosis of hereditary cancers].
Patócs A
Magy Onkol; 2020 Mar; 64(1):25-31. PubMed ID: 32181759
[TBL] [Abstract][Full Text] [Related]
2. Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes.
Paulo P; Pinto P; Peixoto A; Santos C; Pinto C; Rocha P; Veiga I; Soares G; Machado C; Ramos F; Teixeira MR
J Mol Diagn; 2017 Jul; 19(4):502-513. PubMed ID: 28529006
[TBL] [Abstract][Full Text] [Related]
3. Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Lynch Syndrome and Associated Endometrial Cancer.
Tafe LJ
J Mol Diagn; 2015 Sep; 17(5):472-82. PubMed ID: 26162329
[TBL] [Abstract][Full Text] [Related]
4. Uncovering Hereditary Tumor Syndromes: Emerging Role of Surgical Pathology.
Agaimy A; Hartmann A
Semin Diagn Pathol; 2018 May; 35(3):154-160. PubMed ID: 29395463
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study.
Meiser B; Storey B; Quinn V; Rahman B; Andrews L
J Genet Couns; 2016 Apr; 25(2):218-27. PubMed ID: 26259529
[TBL] [Abstract][Full Text] [Related]
6. Pathologists - The watchpersons for hereditary tumor syndromes.
Agaimy A; Wick MR
Semin Diagn Pathol; 2018 May; 35(3):153. PubMed ID: 29409667
[No Abstract] [Full Text] [Related]
7. Principles of molecular testing for hereditary cancer.
Mighton C; Lerner-Ellis JP
Genes Chromosomes Cancer; 2022 Jun; 61(6):356-381. PubMed ID: 35436018
[TBL] [Abstract][Full Text] [Related]
8. Hereditary breast cancer syndromes and genetic testing.
Rich TA; Woodson AH; Litton J; Arun B
J Surg Oncol; 2015 Jan; 111(1):66-80. PubMed ID: 25381882
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes.
Butz H; Blair J; Patócs A
Endocrine; 2021 Mar; 71(3):641-652. PubMed ID: 33570725
[TBL] [Abstract][Full Text] [Related]
10. Next generation immunohistochemistry: Emerging substitutes to genetic testing?
Andrici J; Gill AJ; Hornick JL
Semin Diagn Pathol; 2018 May; 35(3):161-169. PubMed ID: 28662997
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.
Castellanos E; Gel B; Rosas I; Tornero E; Santín S; Pluvinet R; Velasco J; Sumoy L; Del Valle J; Perucho M; Blanco I; Navarro M; Brunet J; Pineda M; Feliubadaló L; Capellá G; Lázaro C; Serra E
Sci Rep; 2017 Jan; 7():39348. PubMed ID: 28051113
[TBL] [Abstract][Full Text] [Related]
12. Gene panel testing for inherited cancer risk.
Hall MJ; Forman AD; Pilarski R; Wiesner G; Giri VN
J Natl Compr Canc Netw; 2014 Sep; 12(9):1339-46. PubMed ID: 25190699
[TBL] [Abstract][Full Text] [Related]
13. [Hereditary cutaneous tumor syndromes].
Hermasch MA; Frank J
Hautarzt; 2019 Jul; 70(7):490-496. PubMed ID: 31143971
[TBL] [Abstract][Full Text] [Related]
14. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
15. [Novel methods and their applicability in the evaluation of the genetic background of endocrine system tumours].
Patócs A; Likó I; Butz H; Baghy K; Rácz K
Orv Hetil; 2015 Dec; 156(51):2063-9. PubMed ID: 26654542
[TBL] [Abstract][Full Text] [Related]
16. The changing approach for identifying hereditary colorectal cancer syndromes.
Laghi L; Ricciardiello L
Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):593-594. PubMed ID: 32651554
[No Abstract] [Full Text] [Related]
17. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
Kamps R; Brandão RD; Bosch BJ; Paulussen AD; Xanthoulea S; Blok MJ; Romano A
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146134
[TBL] [Abstract][Full Text] [Related]
18. Hereditary cancer syndromes, their testing and prevention.
Foretová L
Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
[TBL] [Abstract][Full Text] [Related]
19. Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines.
Marcus RK; Geurts JL; Grzybowski JA; Turaga KK; Clark Gamblin T; Strong KA; Johnston FM
Fam Cancer; 2015 Dec; 14(4):641-9. PubMed ID: 26108897
[TBL] [Abstract][Full Text] [Related]
20. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing.
Spoto CPE; Gullo I; Carneiro F; Montgomery EA; Brosens LAA
Semin Diagn Pathol; 2018 May; 35(3):170-183. PubMed ID: 29397239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
